Drugs target to RYR1

Drug name Drug type Disease/phenotype Mechanism of action(MoA) Phase Status Source
DANTROLENESmall moleculedrug toxicityRyanodine receptor 1 antagonist2.0TerminatedClinicalTrials
DANTROLENE SODIUMSmall moleculeFeverRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENESmall moleculestrokeRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculeWolfram syndromeRyanodine receptor 1 antagonist1.0Active, not recruitingClinicalTrials
DANTROLENESmall moleculemultiple sclerosisRyanodine receptor 1 antagonist1.0RecruitingClinicalTrials
DANTROLENESmall moleculeFeverRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculeSpasticityRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENESmall moleculeSpinal cord injuryRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculeHeat StrokeRyanodine receptor 1 antagonist2.0CompletedClinicalTrials
DANTROLENE SODIUMSmall moleculedrug toxicityRyanodine receptor 1 antagonist2.0TerminatedClinicalTrials
DANTROLENE SODIUMSmall moleculestrokeRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENESmall moleculeventricular tachycardiaRyanodine receptor 1 antagonist2.0RecruitingClinicalTrials
DANTROLENESmall moleculeHeat StrokeRyanodine receptor 1 antagonist2.0CompletedClinicalTrials
DANTROLENESmall moleculecerebral palsyRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENESmall moleculeSpasticityRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENESmall moleculeWolfram syndromeRyanodine receptor 1 antagonist1.0Active, not recruitingClinicalTrials
DANTROLENE SODIUMSmall moleculecerebral palsyRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculeSpinal cord injuryRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENESmall moleculemultiple sclerosisRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENE SODIUMSmall moleculemultiple sclerosisRyanodine receptor 1 antagonist4.0-DailyMed
DANTROLENESmall moleculeFeverRyanodine receptor 1 antagonist2.0TerminatedClinicalTrials
DANTROLENESmall moleculeinjuryRyanodine receptor 1 antagonist2.0RecruitingClinicalTrials